Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 29 studies | 37% ± 16% | |
smooth muscle cell | 19 studies | 38% ± 16% | |
endothelial cell | 12 studies | 27% ± 10% | |
basal cell | 10 studies | 28% ± 12% | |
connective tissue cell | 8 studies | 29% ± 14% | |
fibroblast | 6 studies | 35% ± 19% | |
epithelial cell | 6 studies | 49% ± 16% | |
mesothelial cell | 6 studies | 55% ± 19% | |
myofibroblast cell | 5 studies | 43% ± 31% | |
ciliated cell | 5 studies | 31% ± 6% | |
deuterosomal cell | 4 studies | 33% ± 9% | |
neuron | 4 studies | 37% ± 16% | |
progenitor cell | 3 studies | 40% ± 18% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 24% ± 2% | |
placental villous trophoblast | 3 studies | 79% ± 17% | |
myoepithelial cell | 3 studies | 30% ± 10% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 46% ± 22% | |
hematopoietic stem cell | 3 studies | 25% ± 2% | |
erythroblast | 3 studies | 25% ± 5% | |
secretory cell | 3 studies | 48% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 10881.12 | 180 / 180 | 100% | 277.69 | 429 / 430 |
thymus | 100% | 3128.26 | 652 / 653 | 95% | 104.25 | 573 / 605 |
breast | 99% | 3772.12 | 454 / 459 | 90% | 78.02 | 1011 / 1118 |
pancreas | 100% | 3002.69 | 328 / 328 | 88% | 52.22 | 156 / 178 |
uterus | 100% | 6980.62 | 170 / 170 | 86% | 121.42 | 394 / 459 |
kidney | 100% | 6017.13 | 89 / 89 | 85% | 51.02 | 770 / 901 |
adrenal gland | 100% | 3916.29 | 258 / 258 | 83% | 62.11 | 192 / 230 |
lung | 98% | 2584.55 | 569 / 578 | 78% | 49.63 | 903 / 1155 |
bladder | 100% | 2652.19 | 21 / 21 | 75% | 90.57 | 378 / 504 |
prostate | 100% | 5911.24 | 245 / 245 | 71% | 29.07 | 355 / 502 |
skin | 70% | 1197.96 | 1274 / 1809 | 98% | 163.16 | 461 / 472 |
esophagus | 98% | 2320.12 | 1415 / 1445 | 57% | 35.95 | 105 / 183 |
brain | 93% | 1652.39 | 2451 / 2642 | 52% | 22.08 | 369 / 705 |
intestine | 93% | 1700.64 | 897 / 966 | 35% | 17.80 | 182 / 527 |
stomach | 74% | 991.20 | 266 / 359 | 36% | 19.90 | 102 / 286 |
eye | 0% | 0 | 0 / 0 | 100% | 200.19 | 80 / 80 |
spleen | 100% | 4367.17 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 158.11 | 1 / 1 |
blood vessel | 100% | 5970.31 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2689.27 | 856 / 861 | 0% | 0 | 0 / 0 |
adipose | 99% | 3880.60 | 1194 / 1204 | 0% | 0 | 0 / 0 |
liver | 65% | 729.27 | 146 / 226 | 30% | 30.76 | 123 / 406 |
tonsil | 0% | 0 | 0 / 0 | 67% | 61.98 | 30 / 45 |
muscle | 59% | 674.51 | 476 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 22.48 | 16 / 29 |
peripheral blood | 50% | 658.84 | 467 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008654 | Biological process | phospholipid biosynthetic process |
GO_0006021 | Biological process | inositol biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0004512 | Molecular function | inositol-3-phosphate synthase activity |
Gene name | ISYNA1 |
Protein name | Inositol-3-phosphate synthase 1 Inositol-3-phosphate synthase 1 (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) inositol-3-phosphate synthase (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) Inositol-3-phosphate synthase 1 (IPS 1) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (MI-1-P synthase) (MIP synthase) (hIPS) (Myo-inositol 1-phosphate synthase A1) (hINO1) |
Synonyms | INO1 |
Description | FUNCTION: Key enzyme in myo-inositol biosynthesis pathway that catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol 1-phosphate in a NAD-dependent manner . Rate-limiting enzyme in the synthesis of all inositol-containing compounds . . |
Accessions | J3QRH1 ENST00000457269.8 [Q9NPH2-3] ENST00000577820.5 J3QS51 ENST00000578352.5 ENST00000581672.5 ENST00000582770.6 J3QLD7 J3QKW9 J3QRY0 ENST00000578963.5 [Q9NPH2-2] J3KRH4 ENST00000581800.5 ENST00000338128.13 [Q9NPH2-1] ENST00000583534.1 Q9NPH2 ENST00000582811.6 |